Louisiana lawmakers want more answers from drug companies as families, small businesses and taxpayers continue to face rising prescription costs.
Jason Young, co-founder of Americans for Lower Drug Prices, joined Talk 107.3 to explain Senate Bill 401, authored by Sen. Kirk Talbot of Jefferson Parish. Young said the bill creates more transparency for patients and more accountability for drug makers.
The law requires drug manufacturers to explain, in writing, why prices continue to rise. Those reports will go back to the state Legislature, giving lawmakers more data as they review how drug prices affect Louisiana families, employers and the state budget.
Young said the state has a right to ask for that information because Louisiana spends money on prescriptions through Medicaid, state employee health plans, retirees and other public programs. He also pointed to Texas as an example of a state already requiring similar data from drug makers.
The new board will review 10 drugs first. The law does not name which medications will be selected. Young said the board appointed by the governor will make that decision. He said the review could involve drugs used for diabetes, cancer, insulin or other expensive treatments that force patients to skip doses or ration medicine.
Young also said SB 401 is one piece of a larger effort. Louisiana passed multiple bills aimed at lowering prescription costs, including Senate Bill 387, which focuses on pharmacy benefit managers, and House Bill 1236, which helps protect small independent pharmacies.
Young said Louisiana matters nationally because high drug costs affect patients across the country. He called the state’s approach a practical, bipartisan framework and said other states could watch Louisiana as they look for ways to address rising prescription drug prices.